RE:RE:RE:RE:RE:Detection Upgrades for BioCloudOnce the hardware is in a form which is 'optimized' to greatest extent possible (given all the usual -- and in this segment, amplified -- market imperatives) for wide-scale rollout, then speed is undoubtedly the most important consideration right now. Sales which then provide 'real-world' proof-of-concept will likely take care of all if not most of the required promo and supercharge demand. So, in 'optimizing' the hardware, future-proofing will be part of it. Easily being able to swap out the chamber/associated for a new 'wider-spectrum' component(s) is IMO something they are definitely building into the design. Easy software udpates (if necessary) would also of course be good. I would imagine that for then-existing customers (i.e. who have units that may only detect current virus), KNR would be looking at a model where the swap would be at some sort of favoured rate... Point-is, any possible 'hesitation' based on that aspect that a potential customer for Biocloud may raise will likely easily be 'negotiable' by the team at this stage, even while continue to move as quickly as possible. Great Work KNR. Keep moving! GLTAL.